home / stock / atos / atos news

ATOS News and Press, Atossa Therapeutics Inc. From 03/19/24

Stock Information
Company Name: Atossa Therapeutics Inc.
Stock Symbol: ATOS
Market: NASDAQ
Website: atossatherapeutics.com
Menu
ATOS ATOS Quote ATOS Short ATOS News ATOS Articles ATOS Message Board
Get ATOS Alerts

News, Short Squeeze, Breakout and More Instantly...
ATOS - Atossa climbs after cancer therapy update

2024-03-19 15:51:38 ET More on Atossa Therapeutics Atossa spikes as H.C. Wainwright starts at Buy on lead asset Seeking Alpha’s Quant Rating on Atossa Therapeutics Historical earnings data for Atossa Therapeutics Financial information for Atossa Therap...
ATOS - Atossa Therapeutics Provides Five-Year (Z)-Endoxifen Treatment Update on FDA-Approved "Expanded Access" Program for a U.S. Breast Cancer Patient

SEATTLE, March 19, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), today announced that the pre-menopausal, Estrogen Receptor positive (ER+) / Human Epidermal Growth Factor Receptor 2 negative (HER2-), breast cancer patien...

ATOS - Atossa Therapeutics regains compliance with Nasdaq minimum bid price listing requirements

2024-03-18 08:40:31 ET More on Atossa Therapeutics Atossa spikes as H.C. Wainwright starts at Buy on lead asset Seeking Alpha’s Quant Rating on Atossa Therapeutics Historical earnings data for Atossa Therapeutics Financial information for Atossa Therap...

ATOS - Atossa Therapeutics Appoints Breast Cancer Specialist Tessa Cigler, M.D., M.P.H. to its Board of Directors

SEATTLE, March 12, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) (“Atossa” or the “Company”), a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast ca...
ATOS - Data from Atossa's Phase 2 EVANGELINE Clinical Trial to be Presented at American Association for Cancer Research (AACR) Annual Meeting

SEATTLE, March 06, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS) announced today that data from the 40mg pharmacokinetic (PK) run-in cohort of the ongoing Phase 2 EVANGELINE (Endoxifen Versus exemestANe GosEreLIn) study will be presented at the American Association for Cancer ...

ATOS - Atossa spikes as H.C. Wainwright starts at Buy on lead asset

2024-02-12 13:27:38 ET More on Atossa Therapeutics Seeking Alpha’s Quant Rating on Atossa Therapeutics Historical earnings data for Atossa Therapeutics Financial information for Atossa Therapeutics Read the full article on Seeking Alpha For fur...

ATOS - Atossa Therapeutics Announces Full Enrollment of (Z)-Endoxifen Arm of I-SPY 2 Clinical Trial

SEATTLE, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer, today announced that the (Z)-endoxifen arm of the o...
ATOS - Atossa Therapeutics Announces the Appointment of Arezoo Mirad, M.D., as Senior Medical Director

SEATTLE, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer, today announced the appointment of Dr. Arezoo Mirad...

ATOS - Atossa Therapeutics Announces Full Enrollment of Phase 2 Karisma-Endoxifen Clinical Trial

SEATTLE, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Atossa Therapeutics, Inc. (Nasdaq: ATOS), a clinical stage biopharmaceutical company developing innovative medicines in areas of significant unmet medical need in oncology with a focus on breast cancer, today announced that it has reached full enrollment...

ATOS - Atossa Therapeutics GAAP EPS of -$0.05 beats by $0.02

2023-11-13 14:26:06 ET More on Atossa Therapeutics Atossa Therapeutics: Betting Big On Transforming Old Breast Cancer Care Atossa stock jumps 16% in wake of Cantor overweight rating Seeking Alpha’s Quant Rating on Atossa Therapeutics Historical earning...
Previous 10 Next 10